FI67686C - Foerfarande foer framstaellning av nya terapeutiskt anvaendbara fenetanolaminderivat - Google Patents
Foerfarande foer framstaellning av nya terapeutiskt anvaendbara fenetanolaminderivat Download PDFInfo
- Publication number
- FI67686C FI67686C FI792080A FI792080A FI67686C FI 67686 C FI67686 C FI 67686C FI 792080 A FI792080 A FI 792080A FI 792080 A FI792080 A FI 792080A FI 67686 C FI67686 C FI 67686C
- Authority
- FI
- Finland
- Prior art keywords
- formula
- dimethyl
- compound
- phenyl
- tumor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
- C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US92166878A | 1978-07-03 | 1978-07-03 | |
| US92166878 | 1978-07-03 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI792080A FI792080A (fi) | 1980-01-04 |
| FI67686B FI67686B (fi) | 1985-01-31 |
| FI67686C true FI67686C (fi) | 1985-05-10 |
Family
ID=25445786
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI792080A FI67686C (fi) | 1978-07-03 | 1979-07-02 | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara fenetanolaminderivat |
Country Status (33)
| Country | Link |
|---|---|
| EP (2) | EP0047536B1 (pt) |
| JP (1) | JPS559100A (pt) |
| AR (2) | AR222658A1 (pt) |
| AT (1) | AT370408B (pt) |
| AU (1) | AU521744B2 (pt) |
| BE (1) | BE877392A (pt) |
| BG (3) | BG40482A3 (pt) |
| CA (1) | CA1120058A (pt) |
| CH (1) | CH641759A5 (pt) |
| CS (2) | CS208660B2 (pt) |
| DD (1) | DD144763A5 (pt) |
| DK (1) | DK268579A (pt) |
| EG (1) | EG14400A (pt) |
| ES (2) | ES482153A1 (pt) |
| FI (1) | FI67686C (pt) |
| FR (1) | FR2430409A1 (pt) |
| GB (1) | GB2028800B (pt) |
| GR (1) | GR72546B (pt) |
| HK (1) | HK44087A (pt) |
| HU (1) | HU179170B (pt) |
| IE (1) | IE48436B1 (pt) |
| IL (1) | IL57670A (pt) |
| LU (1) | LU81456A1 (pt) |
| MX (1) | MX6160E (pt) |
| MY (1) | MY8500596A (pt) |
| NZ (1) | NZ190859A (pt) |
| PH (1) | PH15650A (pt) |
| PL (2) | PL123990B1 (pt) |
| PT (1) | PT69840A (pt) |
| RO (2) | RO83053B (pt) |
| SU (2) | SU965351A3 (pt) |
| YU (1) | YU154879A (pt) |
| ZA (1) | ZA793295B (pt) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0006735B1 (en) * | 1978-06-28 | 1983-06-15 | Beecham Group Plc | Secondary amines, their preparation, pharmaceutical compositions containing them and their use |
| NL8105170A (nl) * | 1980-12-10 | 1982-07-01 | Thomae Gmbh Dr K | Nieuwe fenylalkylaminen, werkwijze ter bereiding daarvan en de toepassing daarvan als geneesmiddelen. |
| EP0068669A1 (en) * | 1981-06-20 | 1983-01-05 | Beecham Group Plc | Secondary phenylethanol amines, processes for their preparation and their pharmaceutical application |
| CA1219865A (en) * | 1982-05-14 | 1987-03-31 | Leo Alig | Aziridine phenethanolamine derivatives |
| CA1258454A (en) * | 1982-08-10 | 1989-08-15 | Leo Alig | Phenethanolamines |
| EP0102213A1 (en) * | 1982-08-21 | 1984-03-07 | Beecham Group Plc | Ethanolamine derivatives, pharmaceutical compositions containing them, and processes for preparing them |
| PL144053B1 (en) * | 1983-01-31 | 1988-04-30 | Lilly Co Eli | Method of stimulating growth of domesticated animals,improving effectivness of food utilization ba domesticated animals and improving leanness of domesticated animals and fodder pre-mixture |
| US4849453A (en) * | 1983-01-31 | 1989-07-18 | Eli Lilly And Company | Growth promotion |
| US4569801A (en) * | 1984-10-15 | 1986-02-11 | Eli Lilly And Company | Alkylsulfonamidophenylalkylamines |
| JPS62155213A (ja) * | 1985-12-20 | 1987-07-10 | イ−ライ・リリ−・アンド・カンパニ− | 腫瘍細胞崩壊剤 |
| EG18188A (en) * | 1986-05-01 | 1992-09-30 | Pfizer Ltd | Process for preparation anti-arhythmia agents |
| US5135955A (en) * | 1988-04-25 | 1992-08-04 | Eli Lilly And Company | Propanamine derivatives |
| US5051423A (en) * | 1988-07-13 | 1991-09-24 | Schering Ag | Derivatized alkanolamines as cardiovascular agents |
| US5561142A (en) * | 1994-04-26 | 1996-10-01 | Merck & Co., Inc. | Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity |
| US5541197A (en) * | 1994-04-26 | 1996-07-30 | Merck & Co., Inc. | Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity |
| CN1073983C (zh) * | 1994-10-31 | 2001-10-31 | 中国科学院成都有机化学研究所 | 一种β－拟肾上腺素兴奋剂型饲料添加剂的合成方法 |
| US7547716B2 (en) | 2001-06-08 | 2009-06-16 | Institute Of Medicinal Molecular Design, Inc. | Sulfonamide derivatives |
| TW200740779A (en) | 2005-07-22 | 2007-11-01 | Mitsubishi Pharma Corp | Intermediate compound for synthesizing pharmaceutical agent and production method thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL6610530A (pt) * | 1966-07-27 | 1968-01-29 | ||
| BE757005A (fr) * | 1969-10-02 | 1971-04-02 | Bristol Myers Co | Phenethanolamines substituees et procede pour leur preparation |
| US3801631A (en) * | 1972-02-16 | 1974-04-02 | Mead Johnson & Co | 2'-hydroxy-5'-(1-hydroxy-2-(2-methyl-1-phenyl-2-propylamino)ethyl)meth-anesulfonanilide and its salts |
-
1979
- 1979-06-26 IL IL57670A patent/IL57670A/xx unknown
- 1979-06-26 CA CA000330569A patent/CA1120058A/en not_active Expired
- 1979-06-26 DK DK268579A patent/DK268579A/da not_active Application Discontinuation
- 1979-06-27 PH PH22700A patent/PH15650A/en unknown
- 1979-06-27 EG EG386/79A patent/EG14400A/xx active
- 1979-06-27 NZ NZ190859A patent/NZ190859A/en unknown
- 1979-06-28 AU AU48488/79A patent/AU521744B2/en not_active Ceased
- 1979-06-28 YU YU01548/79A patent/YU154879A/xx unknown
- 1979-06-28 PT PT69840A patent/PT69840A/pt unknown
- 1979-06-29 FR FR7916992A patent/FR2430409A1/fr active Granted
- 1979-06-29 HU HU79EI866A patent/HU179170B/hu unknown
- 1979-07-02 EP EP81109790A patent/EP0047536B1/en not_active Expired
- 1979-07-02 BG BG045920A patent/BG40482A3/xx unknown
- 1979-07-02 RO RO105066A patent/RO83053B/ro unknown
- 1979-07-02 GR GR59488A patent/GR72546B/el unknown
- 1979-07-02 BE BE1/9443A patent/BE877392A/fr not_active IP Right Cessation
- 1979-07-02 CS CS794630A patent/CS208660B2/cs unknown
- 1979-07-02 CS CS794630A patent/CS208661B2/cs unknown
- 1979-07-02 RO RO7998011A patent/RO77731A/ro unknown
- 1979-07-02 BG BG044165A patent/BG40480A3/xx unknown
- 1979-07-02 EP EP79301282A patent/EP0007206B1/en not_active Expired
- 1979-07-02 GB GB7922953A patent/GB2028800B/en not_active Expired
- 1979-07-02 SU SU792786502A patent/SU965351A3/ru active
- 1979-07-02 LU LU81456A patent/LU81456A1/xx unknown
- 1979-07-02 FI FI792080A patent/FI67686C/fi not_active IP Right Cessation
- 1979-07-02 CH CH616479A patent/CH641759A5/fr not_active IP Right Cessation
- 1979-07-02 JP JP8489479A patent/JPS559100A/ja active Granted
- 1979-07-02 BG BG045919A patent/BG40481A3/xx unknown
- 1979-07-02 MX MX798145U patent/MX6160E/es unknown
- 1979-07-03 DD DD79214071A patent/DD144763A5/de unknown
- 1979-07-03 ES ES482153A patent/ES482153A1/es not_active Expired
- 1979-07-03 ZA ZA793295A patent/ZA793295B/xx unknown
- 1979-07-03 PL PL1979222867A patent/PL123990B1/pl unknown
- 1979-07-03 AT AT0463979A patent/AT370408B/de not_active IP Right Cessation
- 1979-07-03 PL PL1979216810A patent/PL119783B1/pl unknown
- 1979-07-03 AR AR277165A patent/AR222658A1/es active
- 1979-08-08 IE IE1231/79A patent/IE48436B1/en unknown
-
1980
- 1980-01-18 ES ES487847A patent/ES487847A0/es active Granted
- 1980-09-12 SU SU802977044A patent/SU931102A3/ru active
- 1980-10-06 AR AR282776A patent/AR222727A1/es active
-
1985
- 1985-12-30 MY MY596/85A patent/MY8500596A/xx unknown
-
1987
- 1987-06-04 HK HK440/87A patent/HK44087A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI67686C (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara fenetanolaminderivat | |
| JP2656699B2 (ja) | 置換ベンジルアミノキヌクリジン | |
| KR880002310B1 (ko) | 펜에탄올 아민류의 제조방법 | |
| JP4685243B2 (ja) | ピリミド［６，１−ａ］イソキノリン−４−オン誘導体 | |
| EP0284621B1 (en) | New psychostimulant agent | |
| JP2003515590A (ja) | 癌を処置するためのクルクミンアナログ | |
| US7759361B2 (en) | Azabicyclooctan-3-one derivatives and use thereof | |
| CA2316223A1 (en) | Hydrophilic coating for an intracorporeal medical device | |
| AU648121B2 (en) | Synergism of HIV reverse transcriptase inhibitors | |
| NZ212856A (en) | Glutarimide derivatives and pharmaceutical compositions | |
| WO1994009001A1 (en) | Pyrroloquinoline bradykinin antagonist | |
| JPH07503703A (ja) | （−）−エゼロリン、（−）−ｎ１−ノルエゼロリンおよび（−）−ｎ１−ベンジルノルエゼロリンの置換フェンゼリンおよびフェニルカルバミン酸塩：特異的アセチルコリンエステラーゼ阻害薬としての使用 | |
| JPS62111962A (ja) | ３−フエニルチオメチルスチレン誘導体 | |
| US6387389B1 (en) | Sustained-release derivatives of hydroxylated analogs of substituted 1-[2[bis(aryl)methoxy]ethyl]-piperazines and -homopiperazines and their use | |
| US4942163A (en) | 1(2H)-isoquinolinones and 1-isoquinolineamines as cancer chemotherapeutic agents | |
| JPH11506453A (ja) | 水溶性カンプトテシン類似体 | |
| CA2196370A1 (en) | Isoprene derivatives | |
| Kam et al. | [(Arylcarbonyl) oxy] propanolamines. 1. Novel. beta.-blockers with ultrashort duration of action | |
| US20020037931A1 (en) | Substituted nitrated catechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them | |
| US4970214A (en) | Quinoline substituted oxomethyl or thioxomethyl glycine derivatives and aldose reductase inhibition therewith | |
| US4528299A (en) | 1-(2,3-Dimethyl-4-methoxyphenyl)-2-methyl-3-(1-pyrrolidinyl)-1-propanone and anti-spastic use thereof | |
| EP4310070A1 (en) | Use of trans amantadine derivative or salt thereof | |
| TWI254707B (en) | Benzazepine derivatives as MAO-B inhibitors | |
| GB1590155A (en) | Cis-4a-phenyl-2,3,4,4a,5,6,7,7a-octahydro-1h-2-pyrindines and pharmaceutical compositions containing them | |
| AU774981B2 (en) | Thiazolopyrimidines useful as TNFalpha inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: ELI LILLY AND COMPANY |